Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for Prevention of Delayed Hyponatremia After Pituitary Macroadenoma Surgery
ChiCTR2600118902Phase 4Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in hyponatraemia comparing tolvaptan group with placebo group (2 arms). Primary endpoint: Incidence of hyponatremia on postoperative day 7. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tolvaptan
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on ChiCTR2600118902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118902.